Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5

NCT00743353 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Sarcoma
Melanoma
Lung Cancer
Breast Cancer
High Grade Gliomas

Interventions

DRUG: F-18 RGD-K5

Sponsor

Siemens Molecular Imaging